Journal article

A multicentre double-blind randomised controlled trial evaluating the efficacy of daily use of antibacterial mouthwash against oropharyngeal gonorrhoea among men who have sex with men: the OMEGA (Oral Mouthwash use to Eradicate GonorrhoeA) study protocol

Eric PF Chow, Sandra Walker, Jane S Hocking, Catriona S Bradshaw, Marcus Y Chen, Sepehr N Tabrizi, Benjamin P Howden, Matthew G Law, Kate Maddaford, Tim RH Read, David A Lewis, David M Whiley, Lei Zhang, Andrew E Grulich, John M Kaldor, Vincent J Cornelisse, Samuel Phillips, Basil Donovan, Anna M McNulty, David J Templeton Show all

BMC INFECTIOUS DISEASES | BMC | Published : 2017

Abstract

BACKGROUND: Gonorrhoea is one of the most common sexually transmissible infections in men who have sex with men (MSM). Gonorrhoea rates have increased substantially in recent years. There is concern that increasing gonorrhoea prevalence will increase the likelihood of worsening antibiotic resistance in Neisseria gonorrhoeae. A recent randomised controlled trial (RCT) demonstrated that a single-dose of mouthwash has an inhibitory effect against oropharyngeal gonorrhoea. We are conducting the first RCT to evaluate whether daily use of mouthwash could reduce the risk of acquiring oropharyngeal gonorrhoea. METHODS/DESIGN: The OMEGA (Oral Mouthwash use to Eradicate GonorrhoeA) study is a double-b..

View full abstract